We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.56B
AUM Growth
-$38.5M
Cap. Flow
-$387M
Cap. Flow %
-24.76%
Top 10 Hldgs %
13.79%
Holding
357
New
58
Increased
94
Reduced
104
Closed
53

Top Buys

Rank Stock Value
1
AGN.PRA
Allergan plc
AGN.PRA
+$15.9M
2
AVGO icon
Broadcom
AVGO
+$7.71M
3
FCAM
Fiat Chrysler Automobiles N.V.
FCAM
+$7.55M
4
VC icon
Visteon
VC
+$6.62M
5
MGM icon
MGM Resorts International
MGM
+$6.53M

Top Sells

Rank Stock Value
1
ACT.PRA
ACTAVIS PLC Pfd Conv Ser A (Irl)
ACT.PRA
+$13.6M
2
VEEV icon
Veeva Systems
VEEV
+$9.49M
3
ALL icon
Allstate
ALL
+$9.41M
4
PAY
Verifone Systems Inc
PAY
+$8.26M
5
URI icon
United Rentals
URI
+$6.43M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.11%
2 Healthcare 12.19%
3 Technology 11.28%
4 Financials 9.06%
5 Industrials 5.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCRX icon
226
Pacira BioSciences
PCRX
$1.02B
$1.88M 0.12%
26,567
+5,611
+27% +$442K
HZO icon
227
MarineMax
HZO
$776M
$1.88M 0.12%
+79,741
New +$1.91M
AVNT icon
228
Avient
AVNT
$3.91B
$1.86M 0.12%
47,515
-15,220
-24% -$594K
PTEN icon
229
Patterson-UTI
PTEN
$3.83B
$1.85M 0.12%
98,347
-30,793
-24% -$639K
ACAD icon
230
Acadia Pharmaceuticals
ACAD
$4.9B
$1.84M 0.12%
43,964
-14,059
-24% -$544K
AVGR
231
DELISTED
Avinger, Inc. Common Stock
AVGR
$1.83M 0.12%
1
– –
POWI icon
232
Power Integrations
POWI
$3.29B
$1.67M 0.11%
+73,774
New +$1.84M
TLGT
233
DELISTED
Teligent, Inc
TLGT
$1.65M 0.11%
26,237
-8,395
-24% -$568K
DSGX icon
234
Descartes Systems
DSGX
$6.67B
$1.56M 0.1%
+96,684
New +$1.5M
SGYP
235
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.54M 0.1%
+185,787
New +$901K
PFNX
236
DELISTED
Pfenex Inc.
PFNX
$1.38M 0.09%
+71,353
New +$1.2M
FTRPR
237
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
$1.23M 0.08%
+12,270
New +$1.23M
ARMH
238
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$1.21M 0.08%
97,199
+1,444
+2% +$75.1K
LOXO
239
DELISTED
Loxo Oncology, Inc
LOXO
$1.13M 0.07%
62,626
-20,111
-24% -$275K
STRR
240
DELISTED
Star Equity Holdings
STRR
$1.08M 0.07%
5,000
– –
KRNY icon
241
Kearny Financial
KRNY
$604M
$1.01M 0.06%
+90,729
New +$946K
OLED icon
242
Universal Display
OLED
$4.01B
$1.01M 0.06%
19,528
-6,267
-24% -$316K
IPHI
243
DELISTED
INPHI CORPORATION
IPHI
$989K 0.06%
+43,242
New +$960K
RAVE icon
244
RAVE Restaurant Group
RAVE
$44.5M
$983K 0.06%
+75,346
New +$1M
GILD icon
245
Gilead Sciences
GILD
$162B
$962K 0.06%
8,220
– –
DOC
246
DELISTED
PHYSICIANS REALTY TRUST
DOC
$958K 0.06%
+62,363
New +$1.03M
NMBL
247
DELISTED
Nimble Storage, Inc.
NMBL
$927K 0.06%
+33,050
New +$862K
HUM icon
248
Humana
HUM
$44.1B
$921K 0.06%
+4,813
New +$893K
NEO icon
249
NeoGenomics
NEO
$2B
$905K 0.06%
167,338
-53,623
-24% -$277K
INSM icon
250
Insmed
INSM
$28.9B
$897K 0.06%
36,737
-20,387
-36% -$463K
8 9
10
11 12

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Nicholas Investment Partners held 357 positions worth $1.56B, down 2.4% from $1.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Nicholas Investment Partners withdrew a net $387M in Q2 2015, closing 53 positions and reducing 104 holdings. Its most notable exit was ACTAVIS PLC Pfd Conv Ser A (Irl), an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Nicholas Investment Partners opened a new position in Allergan plc worth $15.9M.

  • Nicholas Investment Partners's largest Q2 2015 buy was Allergan plc: 15,220 shares worth $15.9M.
  • Nicholas Investment Partners added most to Visteon in Q2 2015, an estimated $6.62M increase.
  • Nicholas Investment Partners's biggest Q2 2015 reduction was Illumina, cutting an estimated $6.06M.
  • Nicholas Investment Partners fully exited ACTAVIS PLC Pfd Conv Ser A (Irl) in Q2 2015, selling an estimated $13.6M.
  • Nicholas Investment Partners's ten largest holdings make up 14% of its $1.56B portfolio in Q2 2015.
  • Nicholas Investment Partners opened 58 new positions and closed 53 in Q2 2015.
  • Nicholas Investment Partners's portfolio value fell 2.4% quarter-over-quarter to $1.56B.

Based on Nicholas Investment Partners's 13F filing for Q2 2015, filed 17 Aug 2015.